Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
09/2003
09/18/2003US20030175935 Method of identifying inhibitors of Lck
09/18/2003US20030175934 Controlling cell differentiation, cell proliferation; anticancer agents
09/18/2003US20030175933 Mutants; detergents; active materials; oxidation resistance
09/18/2003US20030175932 Plant fungicide
09/18/2003US20030175931 DNA molecules coding for debranching enzymes derived from plants
09/18/2003US20030175929 Recombinant human creatine kinase heterodimer with solution-stability
09/18/2003US20030175928 Mitogen-activated protein kinase MEK6 and methods of use therefor
09/18/2003US20030175927 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
09/18/2003US20030175926 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
09/18/2003US20030175925 Nicotinamide ribonucleoside kinase
09/18/2003US20030175924 Human lysophosphatidic acid acyltransferase
09/18/2003US20030175923 Human transferase proteins
09/18/2003US20030175922 Glycoproteins; binding to antibodies; antitumor agents; genetic engineering
09/18/2003US20030175916 Nucleic acid which codes glycerol dehydratase
09/18/2003US20030175913 Anticancer agents; adding stimulants to plant cell culture
09/18/2003US20030175912 Method of producing L-serine by fermentation
09/18/2003US20030175911 Process for the preparation of L-amino acids with amplification of the zwf gene
09/18/2003US20030175910 Whole cell catalyst
09/18/2003US20030175909 Novel thermostable galactose isomerase and tagatose production thereby
09/18/2003US20030175905 Anticholesterol agents; antilipemic agent; antiinflammatory agents; obesity
09/18/2003US20030175903 Recycling system for manipulation of intracellular NADH availability
09/18/2003US20030175902 Methods for producing hyaluronan in a recombinant host cell
09/18/2003US20030175901 Genetic engineering; polyketides
09/18/2003US20030175893 Metabolism mutant; nucleic acid cassette
09/18/2003US20030175892 Amino acid sequences encoding serine protease used in cleaning composition
09/18/2003US20030175888 Discrete acyltransferases associated with type I polyketide synthases and methods of use
09/18/2003US20030175887 Saturation mutagenesis in directed evolution
09/18/2003US20030175886 Used to prevent production of reactive oxygen radicals, oxidative stress
09/18/2003US20030175884 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
09/18/2003US20030175882 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175880 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175879 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175878 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175877 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175875 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175874 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175873 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175872 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175871 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175870 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175869 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175868 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175867 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175866 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175865 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175863 Influenza immunogen and vaccine
09/18/2003US20030175861 Monoterpene synthases from grand fir (abies grandis)
09/18/2003US20030175846 Methods, compositions and apparatuses for detection of gamma-hydroxybutyric acid (GHB)
09/18/2003US20030175829 DSP-4 dual-specificity phosphatase
09/18/2003US20030175816 Antibodies that bind TNF-alpha converting enzyme
09/18/2003US20030175800 Computer readable medium comprising stored atomic coordinate/x-ray diffraction data of D1-C-terminal protease active site; enzyme inhibitors; chloromethylketone tetrapeptides; ligand detection
09/18/2003US20030175791 Comprises enzymatic peptide for treating cancer, psoriasis, arteriosclerosis and inflammation
09/18/2003US20030175786 Comprises nucleotide sequence coding enzymatic polypeptide for diagnosing, preventing and treatment of cell proliferative/differentiation and cancer disorders
09/18/2003US20030175766 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
09/18/2003US20030175758 FabK variant
09/18/2003US20030175757 Comprises enzymatic polypeptide associated with fatty acid biosynthesis (FABK) for diagnosing streptococcus infections; bactericides
09/18/2003US20030175756 Thermus igniterrae nucleic acid polymerases
09/18/2003US20030175752 Comprises nucleotide sequences coding apyrase and/or hydrolase (NDPase) activity for treating or preventing thrombosis; thrombolytic agents
09/18/2003US20030175751 Having substituents such as steroids, reporter molecules/enzymes, non-aromatic lipophilic molecules, peptides, or proteins attached via linking groups; improved diagnosis
09/18/2003US20030175739 Nucleic acids, proteins, and antibodies
09/18/2003US20030175738 Rna polymerase mutants with increased thermostability
09/18/2003US20030175735 Recombinant adenylcyclase and use thereof for screening molecules with proteolytic activity
09/18/2003US20030175732 Chromosomal region containing quantitative trait loci associated with correlating preferential genotype and phenotype with corn digestibility and lignin biosynthesis
09/18/2003US20030175690 Method to evaluate the hiv drug sensitivity
09/18/2003US20030175680 Methods of treating and preventing bone loss
09/18/2003US20030175517 Production of polyelectrolyte capsules by surface precipitation
09/18/2003US20030175289 TIE ligands
09/18/2003US20030175264 Comprises proteolytic enzymes; free of plasminogen activator
09/18/2003US20030175262 Mammalian adhesion protease peptides
09/18/2003US20030175239 Protein crystals are encapsulated within a matrix of a biocompatible polymeric carrier; enhance preservation of the native biologically active tertiary structure of the protein, creates reservoir for slow release of protein when needed
09/18/2003CA2485142A1 Novel n-acetylglucosamine transferase, nucleic acid encoding the same and use thereof in diagnosing cancer and/or tumor
09/18/2003CA2480962A1 Immunogenicity of glucan binding protein
09/18/2003CA2478572A1 Variants of human kallikrein-2 and kallikrein-3 and uses thereof
09/18/2003CA2478522A1 Novel curcuminoid-factor viia constructs as suppressors of tumor growth and angiogenesis
09/18/2003CA2478118A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
09/18/2003CA2478117A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
09/18/2003CA2477980A1 Crystalline structure of human mapkap kinase-2
09/18/2003CA2476938A1 Compositions and methods for preventing and treating cancer via modulating ube1l, isg15 and/or ubp43
09/18/2003CA2475738A1 Activated protein c formulations
09/17/2003EP1344828A1 Novel fructosyl amino acid oxidase
09/17/2003EP1344826A1 Materials comprising and methods of preparation and use for ribosome - inactivating proteins
09/17/2003EP1344821A1 Novel aggrecanase
09/17/2003EP1344820A1 Zygomycetes-origin endoglucanase lacking cellulose-binding domain
09/17/2003EP1343909A2 Methods for large scale protein production in prokaryotes
09/17/2003EP1343903A1 A yeast expression vector and a method of making a recombinant protein by expression in a yeast cell
09/17/2003EP1343902A2 Recombinant porcine liver esterases, their use and a method for the production thereof
09/17/2003EP1343901A2 Novel human kinase interacting protein and polynucleotides encoding the same
09/17/2003EP1343900A2 Oxidoreductases
09/17/2003EP1343899A2 Regulation of human uridine kinase
09/17/2003EP1343898A1 Novel thermostable galactose isomerase and tagatose production thereby
09/17/2003EP1343897A2 Purified active hcv ns2/3 protease
09/17/2003EP1343893A1 Production of stilbenes in transgenic plants and the method of producing thereof
09/17/2003EP1343880A2 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates
09/17/2003EP1343879A1 Methods for isolating novel antimicrobial agents from hypermutable mammalian cells
09/17/2003EP1343878A2 17903, a human aminopeptidase and uses therefor
09/17/2003EP1343877A2 Stable composition comprising a nuclease and a phosphatase
09/17/2003EP1343876A2 Modulators of activity of g-protein-coupled receptor kinases
09/17/2003EP1343875A2 Sugar beet genes involved in stress tolerance
09/17/2003EP1343874A2 3-hydroxypropionic acid and other organic compounds
09/17/2003EP1343873A1 A method for the purification of chymosin